Old and new uses of surfactant

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue SUPPL. 3, 2010, Pages 41-44

  Gizzi, Camilla ^a   Papoff, Paola ^b   Barbàra, Caterina Silvia ^b   Cangiano, Giulia ^b   Midulla, Fabio ^b   Moretti, Corrado ^b  

^a S Giovanni Calibita Hospital   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute respiratory distress syndrome; children; infant; infection; surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BERACTANT; LUCINACTANT; PLACEBO; PORACTANT; LUNG SURFACTANT;

ACUTE LUNG INJURY; CHRONIC LUNG DISEASE; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EARLY INTERVENTION; GROUP B STREPTOCOCCAL INFECTION; HUMAN; HYPOTENSION; HYPOXIA; INFANT; INTERMETHOD COMPARISON; LIVER CELL DAMAGE; LOW DRUG DOSE; LUNG ALVEOLUS CELL TYPE 2; LUNG DYSPLASIA; LUNG HEMORRHAGE; MECONIUM ASPIRATION; MINIMALLY INVASIVE PROCEDURE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INTENSIVE CARE; OPTIMAL DRUG DOSE; OVERALL SURVIVAL; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPEATED DRUG DOSE; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SUBSTITUTION THERAPY; SURVIVAL RATE; VIRAL RESPIRATORY TRACT INFECTION; DRUG REPOSITIONING; EVALUATION; METHODOLOGY; NEWBORN; PREMATURITY; RESPIRATORY TRACT DISEASE;

DRUG REPOSITIONING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE, NEONATAL; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY TRACT DISEASES;

EID: 77957940717     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.509912     Document Type: Review

References (20)

1. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Halliday HL; European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update. Neonatology 2010;97:402-417.
2. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008;358:700-708.
3. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362:1970-1979.
4. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009;123:137-142.
5. Dani C, Corsini I, Bertini G, Fontanelli G, Pratesi S, Rubaltelli FF. The INSURE method in preterm infants of less than 30 weeks gestation. J Matern Fetal Neonatal Med 2010 Feb 25. [Epub ahead of print].
6. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, Mosca F, Nona J, Thomson M, Verder H, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010;125:e1402-e1409.
7. Sai Sunil KM, Dutta S, Kumar P. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome. Acta Paediatr 2009;98:1412-1415.
8. Sweet DG, Halliday HL. The use of surfactants in 2009. Arch Dis Child Educ Pract Ed 2009;94:78-83.
9. El Shahed AI, Dargaville P, Ohlsson A, Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev 2007;3:CD002054.
10. Been JV, Rours IG, Kornelisse RF, Jonkers F, de Krijger RR, Zimmermann LJ. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr 2010;156:10.e1-15.e1.
11. Laughon M, Bose C, Moya F, Aschner J, Donn SM, Morabito C, Cummings JJ, Segal R, Guardia C, Liu G; Surfaxin Study Group. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia. Pediatrics 2009;123:89-96.
12. Kuo HT, Lin HC, Tsai CH, Chouc IC, Yeh TF. A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants. J Pediatr 2010;156:537-541.
13. Sato A, Whitsett JA, Scheule RK, Ikegami M. Surfactant protein-d inhibits lung inflammation caused by ventilation in premature newborn lambs. Am J Respir Crit Care Med 2010; 181:1098-1105.
14. Moya F. Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials. J Perinatol 2009;29 (Suppl 2): S23-S238.
15. Almlén A, Walther FJ, Waring AJ, Robertson B, Johansson J, Curstedt T. Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits. Neonatology 2010;98:91-99.
16. Adhikari N, Burns KE, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2004;4:CD004477.
17. Willson DF, Chess PR, Notter RH. Surfactant for pediatric acute lung injury. Pediatr Clin North Am 2008;55:545-575, ix.
18. Duffett M, Choong K, Ng V, Randolph A, Cook DJ. Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis. Crit Care 2007;11: R66.
19. Skelton R, Holland P, Darowski M, Chetcuti PA, Morgan LW, Harwood JL. Abnormal surfactant composition and activity in severe bronchiolitis. Acta Paediatr 1999;88:942-946.
20. Kneyber MC, Plotz FB, Kimpen JL. Bench-to-bedside review: paediatric viral lower respiratory tract disease necessitating mechanical ventilation - should we use exogenous surfactant? Crit Care 2005;9:550-555.